According to a recent analysis by DelveInsight, the global protein expression market is poised for strong growth, projected to reach USD 6,491.18 million by 2032, expanding at a CAGR of 7.67% during the forecast period from 2025 to 2032. This growth trajectory underscores the increasing importance of protein expression technologies across biopharmaceutical development, life science research, and personalized medicine.
Protein Expression Market Overview
Protein expression is a fundamental biological process in which genetic information encoded in DNA is transcribed into mRNA and translated into functional proteins. This process is critical for cellular activity, immune response, enzyme function, and therapeutic protein production. In research and clinical settings, protein expression plays a vital role in understanding disease pathways, enabling drug discovery, and supporting the large-scale production of biologics.
The expansion of the protein expression market is primarily driven by the rising prevalence of chronic and complex diseases, which has significantly boosted demand for biologics such as monoclonal antibodies, vaccines, and recombinant proteins. In parallel, increasing investments in proteomics, structural biology, and therapeutic protein manufacturing, along with continuous advancements in expression systems, are further accelerating market adoption worldwide.
DelveInsight’s report titled “Protein Expression Market Insights, Competitive Landscape and Market Forecast – 2032” offers a comprehensive evaluation of current and future market trends. The study provides in-depth analysis of market drivers, challenges, barriers, and emerging technologies, while also profiling key players actively shaping the competitive landscape.
To know more about why North America is leading the market growth in the Protein Expression market, get a snapshot of the report Protein Expression Market Trends
Protein Expression Market Size and Regional Insights
DelveInsight estimates that the global protein expression market was valued at approximately USD 3,603.20 million in 2024. North America is expected to maintain its dominance, holding the largest market share in 2024. Factors such as the high incidence of cancer, robust biotech infrastructure, strong funding for R&D, and close collaboration between academic institutions and industry players are fueling regional growth. Additionally, increasing demand for advanced protein-based therapeutics continues to strengthen North America’s leadership position.
Recent Developments Driving Growth of Protein Expression Market
Ongoing innovation is a key contributor to market momentum. In June 2024, Syngene International Ltd. introduced a new protein production platform combining transposon-based cell line technology with proprietary clone development processes. Earlier, in July 2023, Lonza Bioscience launched the TheraPRO CHO Media System, designed to improve productivity and protein quality in GS-CHO cell lines, enabling faster and more efficient therapeutic protein development.
Strategic mergers and acquisitions are also shaping the market. Acquisitions such as BigHat Biosciences’ purchase of Frugi Biotechnology and Moderna’s acquisition of OriCiro Genomics highlight the growing focus on cell-free protein expression technologies, which are expected to generate significant revenue opportunities over the coming years.
To read more about the latest highlights related to Protein Expression, get a snapshot of the key highlights entailed in the Protein Expression Market Insights
Protein Expression Competitive Landscape
The protein expression market is highly competitive, with key players including Agilent Technologies (NYSE: A), Thermo Fisher Scientific (NYSE: TMO), Merck KGaA (ETR: MRK), Lonza Bioscience (SWX: LONN), Promega, Bio-Rad Laboratories (NYSE: BIO), QIAGEN (FRA: QIA), Genscript Biotech (HKG: 1548), and others actively investing in innovation and expansion strategies.
Scope of the Protein Expression Market Report
The DelveInsight report provides global coverage across North America, Europe, Asia-Pacific, and Rest of the World, with detailed segmentation by expression systems, products, applications, end-users, and geography. It also includes Porter’s Five Forces analysis, company profiles, KOL insights, and analyst viewpoints, offering stakeholders a holistic understanding of the market.
Interested in knowing how the Protein Expression market will grow by 2032? Click to get a snapshot of the Protein Expression Market Analysis
About DelveInsight
DelveInsight is a leading life sciences market research and business consulting firm, delivering end-to-end solutions for pharmaceutical, biotech, and MedTech companies. Through its subscription-based platform PharmDelve, DelveInsight enables seamless access to high-quality healthcare and pharma market intelligence.
